Compounds useful for inhibiting RET kinase

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11964968
APP PUB NO 20230312544A1
SERIAL NO

18165037

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are RET kinase inhibitors according to the formula:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LOXO ONCOLOGY INCLILLY CORPORATE CENTER INDIANAPOLIS IN 46285

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Anderson, Erin D Boulder, US 4 3
Andrews, Steven W Longmont, US 121 3409
Condroski, Kevin R Lafayette, US 24 795
Irvin, Thomas C Erie, US 4 3
Kolakowski, Gabrielle R Longmont, US 73 976
Kumar, Manoj Longmont, US 337 4728
McFaddin, Elizabeth A Nederland, US 21 151
McKenney, Megan Boulder, US 2 2
Munchhof, Michael J Corvallis, US 42 706
Welch, Michael B Westminster, US 2 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Oct 23, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 23, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 23, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00